Stockscreener 앱 받기
2.87
1.37%
-0.04
Glucotrack Inc 주식(GCTK)의 최신 뉴스
Glucotrack Appoints Andy Balo To Its Board Of Directors - MPO-mag
Glucotrack appoints biotech veteran to board amid expansion By Investing.com - Investing.com Canada
Glucotrack appoints biotech veteran to board amid expansion - Investing.com
Glucotrack appoints biotech veteran to board amid expansion By Investing.com - Investing.com Australia
GlucoTrack appoints John Ballantyne to board of directors - TipRanks
JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS - StockTitan
Glucotrack Wins New Funding For Continuous Blood Glucose Monitor - MPO-mag
Head-To-Head Analysis: GlucoTrack (NASDAQ:GCTK) vs. Tactile Systems Technology (NASDAQ:TCMD) - Defense World
Glucotrack appoints new VP for clinical trials - Investing.com India
Glucotrack appoints new VP for clinical trials - Investing.com
GlucoTrack Welcomes New VP of Clinical Operations - TipRanks
GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS - StockTitan
GlucoTrack appoints Sandie Martha as VP, clinical operations - TipRanks
Glucotrack's Innovative Continuous Blood Glucose Monitor Aims to Revolutionize Diabetes Management - Vancity Buzz
Poster Presentations, Upcoming Human Trials, Recently Secured Fu - News Channel Nebraska
GCTK Stock Earnings: GlucoTrack Reported Results for Q2 2024 - MSN
Glucotrack survey highlights interest in 3-year CBGM - Drug Delivery Business News
Glucotrack reveals positive feedback on new diabetes monitor - Investing.com
GlucoTrack Shares Market Research Insights Publicly - TipRanks
Glucotrack’s Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference - ForexTV.com
Glucotrack’s Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference - StockTitan
GCTK Stock Earnings: GlucoTrack Reported Results for Q2 2024 - InvestorPlace
Glucotrack Augments Clinical Evidence for its Epidural Continuous Glucose Monitoring Tech - MPO-mag
GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE - ForexTV.com
GlucoTrack (NASDAQ:GCTK) Stock Price Down 4.4% - Defense World
GlucoTrack eyes human trials for implantable blood glucose monitor - MSN
GlucoTrack Showcases Innovations at Industry Conference - TipRanks
GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE - StockTitan
GlucoTrack Secures $4M Funding and Expands Board Amid Reshuffle - TipRanks
GLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS CONTINUOUS BLOOD GLUCOSE MONITOR - StockTitan
GlucoTrack secures $4M funding from its leading shareholder for CBGM trial - TipRanks
BNP Paribas Financial Markets Decreases Stock Holdings in Helios Technologies, Inc. (NASDAQ:HLIO) - Defense World
ZEN Graphene Solutions (OTCMKTS:ZENYF) Stock Crosses Above 50 Day Moving Average of $2.84 - Defense World
Falcon Oil & Gas (CVE:FO) Stock Price Passes Above 50 Day Moving Average of $0.11 - Defense World
BNP Paribas Financial Markets Boosts Position in Despegar.com, Corp. (NYSE:DESP) - Defense World
Ultimate Sports Group (LON:USG) Stock Price Passes Below 50 Day Moving Average of $27.50 - Defense World
Janney Montgomery Scott LLC Acquires 14,977 Shares of FS KKR Capital Corp. (NYSE:FSK) - Defense World
Wag! Group (NASDAQ:PET) Given New $3.50 Price Target at Roth Mkm - Defense World
The European Smaller Companies Trust (LON:ESCT) Stock Price Down 0.2% - Defense World
EQT Co. (NYSE:EQT) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Athersys (NASDAQ:ATHX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Focus collaborates with Glucotrack on implantable CBGM - Drug Delivery Business News
Non-Invasive Glucose Meter Market SWOT and PESTAL Analysis | 2032 - WICZ
GlucoTrack Shares Company Status Update with Shareholders - TipRanks
GlucoTrack (NASDAQ:GCTK) and Cerus (NASDAQ:CERS) Head to Head Analysis - Defense World
Glucotrack Has More Data For Implantable Blood Glucose Monitor - MPO-mag
GlucoTrack (NASDAQ:GCTK) Trading 2.9% Higher - Defense World
Integrity Applications to Present and Exhibit at the 2013 Meeting of the European Association for th - Yahoo Movies UK
Integrity Applications to Present at the Sidoti & Company Semi-Annual Microcap Conference - AOL
Glucotrack adds diabetes tech veteran to board By Investing.com - Investing.com
GlucoTrack Elevates Board and Streamlines Governance ProcessesTipRanks.com - TipRanks
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS - StockTitan
Glucotrack Appoints Andy Balo to Board of Directors - citybiz
GCTKGlucoTrack, Inc. Latest Stock News & Market Updates - StockTitan
GlucoTrack, Inc. (NASDAQ:GCTK) Sees Significant Growth in Short Interest - Defense World
GlucoTrack completes preclinical study of epidural glucose monitoring sensorTipRanks.com - TipRanks
Bulldog Investors LLP Raises Stake in MFS Investment Grade Municipal Trust (NYSE:CXH) - Defense World
GlucoTrack Advances with Successful Preclinical StudyTipRanks.com - TipRanks
GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR - ForexTV.com
GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY ... - StockTitan
1.28%
0.96%
자본화:
|
볼륨(24시간):